Bayer CropScience Past Earnings Performance
Past criteria checks 5/6
Bayer CropScience has been growing earnings at an average annual rate of 21.9%, while the Chemicals industry saw earnings growing at 16.6% annually. Revenues have been growing at an average rate of 13.6% per year. Bayer CropScience's return on equity is 25.6%, and it has net margins of 15.2%.
Key information
21.9%
Earnings growth rate
19.3%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 13.6% |
| Return on equity | 25.6% |
| Net Margin | 15.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Bayer CropScience makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 52,942 | 8,030 | 7,684 | 0 |
| 30 Sep 23 | 53,772 | 8,444 | 8,020 | 0 |
| 30 Jun 23 | 52,119 | 7,841 | 8,299 | 0 |
| 31 Mar 23 | 51,397 | 7,582 | 8,627 | 0 |
| 31 Dec 22 | 51,205 | 7,524 | 8,381 | 0 |
| 30 Sep 22 | 50,727 | 7,027 | 8,313 | 0 |
| 30 Jun 22 | 49,859 | 6,942 | 8,027 | 0 |
| 31 Mar 22 | 47,344 | 6,453 | 7,836 | 0 |
| 31 Dec 21 | 45,048 | 5,545 | 6,549 | 0 |
| 30 Sep 21 | 44,329 | 4,246 | 6,090 | 0 |
| 30 Jun 21 | 44,494 | 4,951 | 5,858 | 0 |
| 31 Mar 21 | 42,613 | 4,931 | 5,726 | 0 |
| 31 Dec 20 | 39,913 | 4,627 | 5,706 | 0 |
| 30 Sep 20 | 39,271 | 6,457 | 5,559 | 0 |
| 30 Jun 20 | 38,918 | 5,909 | 5,703 | 0 |
| 31 Mar 20 | 36,094 | 4,745 | 5,729 | 0 |
| 31 Dec 19 | 29,294 | 2,864 | 5,437 | 0 |
| 30 Sep 19 | 28,505 | 2,116 | 5,580 | 0 |
| 30 Jun 19 | 25,256 | 1,497 | 5,427 | 0 |
| 31 Mar 19 | 31,754 | 3,371 | 6,010 | 0 |
| 31 Dec 18 | 28,639 | 3,045 | 4,621 | 0 |
| 30 Sep 18 | 27,226 | 2,877 | 4,476 | 0 |
| 30 Jun 18 | 28,505 | 3,356 | 4,392 | 0 |
| 31 Mar 18 | 27,167 | 3,001 | 4,327 | 0 |
| 31 Dec 17 | 26,375 | 2,769 | 4,280 | 0 |
| 30 Sep 17 | 28,203 | 3,030 | 4,242 | 0 |
| 30 Jun 17 | 26,796 | 2,715 | 2,507 | 0 |
| 31 Mar 17 | 28,153 | 2,910 | 4,129 | 0 |
| 31 Dec 16 | 40,105 | 3,323 | 4,219 | 0 |
| 30 Sep 16 | 32,030 | 3,342 | 3,519 | 0 |
| 30 Jun 16 | 38,027 | 3,215 | 4,116 | 0 |
| 31 Mar 16 | 27,838 | 3,151 | 4,073 | 0 |
| 31 Dec 15 | 37,919 | 3,278 | 6,458 | 0 |
| 30 Sep 15 | 38,569 | 3,554 | 6,469 | 0 |
| 30 Jun 15 | 39,222 | 3,814 | 6,433 | 0 |
| 31 Mar 15 | 37,233 | 3,830 | 3,994 | 0 |
| 31 Dec 14 | 36,996 | 3,858 | 6,335 | 0 |
| 30 Sep 14 | 36,390 | 3,698 | 6,347 | 0 |
| 30 Jun 14 | 34,513 | 3,102 | 2,146 | 0 |
| 31 Mar 14 | 32,452 | 2,895 | 6,223 | 0 |
| 31 Dec 13 | 30,870 | 3,151 | 5,445 | 0 |
| 30 Sep 13 | 30,195 | 11,794 | 5,348 | 0 |
| 30 Jun 13 | 27,922 | 11,608 | 1,884 | 0 |
Quality Earnings: 506285 has high quality earnings.
Growing Profit Margin: 506285's current net profit margins (15.2%) are higher than last year (14.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 506285's earnings have grown significantly by 21.9% per year over the past 5 years.
Accelerating Growth: 506285's earnings growth over the past year (6.7%) is below its 5-year average (21.9% per year).
Earnings vs Industry: 506285 earnings growth over the past year (6.7%) exceeded the Chemicals industry -6.1%.
Return on Equity
High ROE: 506285's Return on Equity (25.6%) is considered high.